Skip to Content

Perjeta

Licence status
Authorised: 04/03/2013
Active substances
Pertuzumab
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/13/813/001
Licence holder
Roche Registration GmbH

Licence information

ATC code
L01XC Monoclonal antibodies, L01XC13 pertuzumab
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
04/03/2013

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie